1 / 8

Liquid Biopsy Market Report Analysis 2020-2026

Liquid Biopsy is a conventional method used to diagnose onset of cancer. The alternative names for liquid biopsy are fluid biopsy or fluid phase biopsy. This is largely a non-invasive method used to track tumors and mutations over a period of time. Doctors are informed about the disease with the help of these observations of the tumoru2019s future.

priyankauke2013
Download Presentation

Liquid Biopsy Market Report Analysis 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liquid Biopsy MarketSet to Exceed $3,362.6 Million by 2026 | CAGR 21.9% “Liquid Biopsy Market Share, Size, Trends, & Industry Analysis Report, By Technology (PCR Microarrays, NGS); By Sample Type (Blood, Urine, Saliva, Other Body Fluid); By Biomarker (Exosomes, CTC, ctDNA); By Application; By Region and Segment Forecast, 2019-2026”

  2. Liquid Biopsy Market Estimate & Forecast to 2026 The global liquid biopsy market size is slated to reach USD 3,362.6 million by 2026 at a CAGR of 21.9% according to a news report published by Polaris Market Research. Liquid Biopsy is a conventional method used to diagnose onset of cancer. The alternative names for liquid biopsy are fluid biopsy or fluid phase biopsy. This is largely a non-invasive method used to track tumors and mutations over a period of time. Doctors are informed about the disease with the help of these observations of the tumor’s future. Though being simple and instrumental in early stage detection of cancer, it voices concerns over its adoption.  Liquid Biopsy products market has a shortcoming which is it is largely overshadowed by tissue biopsy with the latter being adopted exceptionally. Drivers to the market potential are the increasing number of patients being diagnosed with various types of cancer. The free trials accompanying surgery motivates growth. Minimal invasive surgery method unique to liquid biopsy market cap, invokes huge demand impacting market growth over forthcoming years. A significant driver to growth of liquid biopsy is the reduced number of surgical invasions. This encouraging sign makes it one of the most adopted substitutes for tissue biopsy. An increasing trend followed by key players to shift focus onto research and development activities aiding strategic M&A improves market strength dramatically.

  3. Liquid Biopsy Market Scope Request for sample

  4. Liquid Biopsy Market Estimate & Forecast to 2026 Considering the basis of technology, single gene analysis and multi-gene-parallel analysis (NGS) dominate the liquid biopsy cancer market size. NGS denotes diagnosis of multiple diseases at one instance. PCR is an approach to analyzing mutation among genes. Yet another class of distinction in liquid biopsy market 2018 is based on sample type. The sample is segmented on basis of blood, saliva, urine and other body fluid. Blood sample is the best sample type for customary analyses as blood contains cell free DNA, circulating cell and exosomes that offer them for easy detection leading to detection of cancerous cells in human body.     North America is holding coveted position as per geography in market cap during forecast period. Increased facilitators for diagnosis of cancer and rising number of patients suffering from cancer are factors promoting growth of market. Asia Pacific is exhibited to grow at a faster rate during forecast period. The major players operating in market include Roche Diagnostics, Illumina Inc., Myriad Genetics, Inc., RainDance Technologies, Inc. among others. Browse Complete Report

  5. Liquid Biopsy Market Size Request for TOC

  6. Liquid Biopsy Market Study – Engagement Options Buy Now – Click Here! Buy now & have immediate access to premium insights Purchase Report Sections – Click Here! Regional analysis Segmentation analysis Industry outlook Competitive landscape Speak To Analyst – Click Here! Get your doubts clear Schedule a call with our analyst before making any decision Request For Sample Pages – Click Here! Get free sample pages Understand report structure Unmask data for validation

  7. About Us Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to e present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com

  8. Thank You! Contact Us : Polaris Market Research30 Wall Street8th Floor, New York City, NY 10005,United States E mail Id: sales@polarismarketresearch.com Phone: +1-646-568-9980

More Related